deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT01452529

Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain

A Multicenter, Randomized, Double-blind, Placebo-controlled Study With an Open-label Run-in to Assess the Efficacy and Safety of Hydrocodone Bitartrate (HYD) Tablets 20 to 120 mg Once-daily in Subjects With Moderate to Severe Chronic Low Back Pain

Sponsor: Purdue Pharma LP

Updated 10 times since 2017 Last updated: Mar 2, 2020 Started: Oct 31, 2011 Primary completion: Sep 30, 2013 Completion: Oct 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Chronic Low Back Pain, this trial is completed. The trial is conducted by Purdue Pharma LP and has accumulated 10 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Nov 2017 · 9 months · monthly snapshotCompleted~Nov 2017 – ~Jun 2018 · 7 months · monthly snapshotCompleted~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotCompleted~Jul 2018 – ~Apr 2020 · 21 months · monthly snapshotCompleted~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

10 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Apr 2020 — Jan 2021 [monthly]

    Completed PHASE3

Show 5 earlier versions
  1. Jul 2018 — Apr 2020 [monthly]

    Completed PHASE3

  2. Jun 2018 — Jul 2018 [monthly]

    Completed PHASE3

  3. Nov 2017 — Jun 2018 [monthly]

    Completed PHASE3

  4. Feb 2017 — Nov 2017 [monthly]

    Completed PHASE3

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Purdue Pharma LP
Data source: Purdue Pharma LP

For direct contact, visit the study record on ClinicalTrials.gov .